The bioactive peptide market comprises protein fragments that influence body functions in positive ways beyond basic nutrition. Bioactive peptides are usually derived from milk, eggs, meat, seafood and plant products. They exert specific physiological effects in the body such as anti-hypertensive, antidiabetic, antioxidant, antimicrobial and anti-inflammatory properties. The increasing awareness about the role of nutrition in maintaining health and prevention of diseases has boosted the demand for bioactive peptides.

The Global Bioactive Peptide Market is estimated to be valued at US$ 11.29 Bn in 2024 and is expected to exhibit a CAGR of 8.0% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the bioactive peptide market are Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS. The increasing awareness about health benefits of bioactive peptides is fueling their demand globally. Rising prevalence of chronic diseases and growing geriatric population prone to health issues are the key factors supplementing the market growth. Technological advancements have enabled efficient production of bioactive peptides through microbial fermentation, enzymatic hydrolysis and chemical synthesis.

Market Trends

The growing popularity of functional foods and nutraceuticals containing Bioactive Peptide Market Demand is one of the key trends in the market. Manufacturers are increasingly exploiting the bioactive properties of proteins through fermentation and enzymatic processes to develop novel functional ingredients. Another major trend is the incorporation of bioactive peptides in cosmeceuticals and personal care owing to their anti-aging properties.

Market Opportunities

The untapped potential of plant-based bioactive peptides present lucrative opportunities for market players. With the rising vegan and flexitarian trends, biomanufacturers are exploring new plant sources for commercialization. The potential application of bioactive peptides in therapeutics also offers promising growth prospects. Ongoing R&D focusing on novel sourcing and precision production technologies will expand the applications of bioactive peptides.

Impact of COVID-19 on Bioactive Peptide Market

The COVID-19 pandemic has significantly impacted the growth of the global bioactive peptide market. During the initial phase of the pandemic, lockdowns and restrictions imposed worldwide disrupted the supply chain and led to delays in production and shipping of bioactive peptides. This negatively impacted the market growth in 2020. However, as the pandemic intensified, the demand for bioactive peptides increased substantially due to their immunity boosting and therapeutic properties. Various research studies showed bioactive peptides can help enhance immunity against viral infections. This surge in demand helped drive the market during the pandemic. With growing focus on healthcare nutrition and preventive care, the application of bioactive peptides further expanded in clinical and food and beverage sectors.

Moving forward, the long-term impact of the pandemic is projected to accelerate the market growth. The increased awareness around health, nutrition and immunity is prompting consumers towards functional supplements and fortified foods containing bioactive peptides. The demand from pharmaceutical companies has risen as clinical research on bioactive peptides is gaining momentum for developing therapeutics against chronic and infectious diseases. While supply chain issues continue to interrupt the production temporarily, major market players are focusing on establishing efficient distribution networks and adopting innovative production techniques to cater to the increasing global demand in the post-pandemic era. Strategic partnerships between bioactive peptide producers and end-use industries are also expected to boost market opportunities.

Europe accounts for the largest share of the global bioactive peptide market in terms of value. The concentration of major pharma/biotech companies, developed healthcare infrastructure and awareness about functional ingredients have contributed to the large market size of the region. North America holds the second largest market and is anticipated to witness the fastest growth during the forecast period. Growing health-conscious population, rising incidents of lifestyle diseases and expanding clinical applications of bioactive peptides are factors accelerating the market growth in North America. Asia Pacific is emerging as one of the fastest growing regional markets with increasing foreign investments, evolving consumer preferences and improving healthcare sectors across various countries. China, India, Japan and South Korea are recognized as the most lucrative country-level markets in Asia Pacific.

The highest growth potential in the global bioactive peptide market exists in Asia Pacific region driven by rising income levels, healthcare expenditure, burgeoning middle-class population and their growing interest in nutrition and well-being products. Many Asian countries are experiencing rapid urbanization with evolving lifestyles and increasing spending on premium health supplements. Several government initiatives are also supporting the growth of biotechnology and nutraceutical industries in the region. This has prompted key market players to expand production facilities and distribution networks in high potential Asian countries. Rising awareness, improving regulations and presence of opportunities across application sectors will likely propel the bioactive peptide market growth in Asia Pacific to new highs in the near future.

Get More Insights on- Bioactive Peptide Market